(Q37801939)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964610%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964610%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964610%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Carolina Constantin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964610%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Cristiana Tanase

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964610%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

1 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964610%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964610%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964610%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964610%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

897-919

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964610%20AND%20SRC:MED&resulttype=core&format=json

Spontaneous regression of metastases from melanoma: review of the literature

15 February 2020

cites work

1 reference

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

Tumor immunoediting and immunosculpting pathways to cancer progression.

21 January 2018

1 reference

Immunosuppression and melanocyte proliferation

21 January 2018

1 reference

Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment

21 January 2018

1 reference

Immune modulation by melanoma-derived factors

21 January 2018

1 reference

The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans

21 January 2018

1 reference

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis

21 January 2018

1 reference

A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans

21 January 2018

1 reference

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma

21 January 2018

1 reference

Immunohistochemical characteristics of melanoma

21 January 2018

1 reference

Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels.

21 January 2018

1 reference

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

21 January 2018

1 reference

p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma.

21 January 2018

1 reference

Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma

21 January 2018

1 reference

FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma

21 January 2018

1 reference

Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma

21 January 2018

1 reference

Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma

21 January 2018

1 reference

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

21 January 2018

1 reference

Primary cutaneous melanoma: an 18-year study

21 January 2018

1 reference

Downregulation of tapasin expression in progressive human malignant melanoma

21 January 2018

1 reference

Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis

21 January 2018

1 reference

Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis

21 January 2018

1 reference

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is expressed in normal skin and cutaneous inflammatory diseases, but not in chronically UV-exposed skin and non-melanoma skin cancer.

21 January 2018

1 reference

Selection for TRAIL resistance results in melanoma cells with high proliferative potential

21 January 2018

1 reference

Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor–related apoptosis-inducing ligand

21 January 2018

1 reference

High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients

21 January 2018

1 reference

Multiple desmoplastic cellular neurothekeomas localized to the face of a 16-year-old boy.

21 January 2018

1 reference

The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions.

21 January 2018

1 reference

Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer

21 January 2018

1 reference

Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines

21 January 2018

1 reference

Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting

21 January 2018

1 reference

Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate.

21 January 2018

1 reference

Melanoma gene expression and clinical course

21 January 2018

1 reference

Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab?

21 January 2018

1 reference

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

CD4+ Tregs and immune control

21 January 2018

1 reference

Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells

21 January 2018

1 reference

IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin

21 January 2018

1 reference

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

Comparison of stable human Treg and Th clones by transcriptional profiling.

21 January 2018

1 reference

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

21 January 2018

1 reference

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.

21 January 2018

1 reference

IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma

21 January 2018

1 reference

CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma

21 January 2018

1 reference

The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment

21 January 2018

1 reference

Immune functions of the skin

21 January 2018

1 reference

Increased survival from stage IV melanoma associated with fewer regulatory T Cells

21 January 2018

1 reference

Stem cells in melanoma development

21 January 2018

1 reference

Cancer stem cells: lessons from melanoma

21 January 2018

1 reference

Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta ) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes

21 January 2018

1 reference

Identification of cells initiating human melanomas

21 January 2018

1 reference

Modulation of T-cell activation by malignant melanoma initiating cells

21 January 2018

1 reference

Pretreatment serum interleukin-6 concentration as a prognostic factor of overall survival in metastatic malignant melanoma patients treated with biochemotherapy: a retrospective study

21 January 2018

1 reference

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.

21 January 2018

1 reference

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells

21 January 2018

1 reference

Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

21 January 2018

1 reference

Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients

21 January 2018

1 reference

Active Notch1 confers a transformed phenotype to primary human melanocytes

21 January 2018

1 reference

Induction of CCL2 by siMAML1 through upregulation of TweakR in melanoma cells

21 January 2018

1 reference

Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.

21 January 2018

1 reference

Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.

21 January 2018

1 reference

Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma

21 January 2018

1 reference

Key signaling molecules in pituitary tumors

21 January 2018

1 reference

Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model

21 January 2018

1 reference

Early detection of melanoma progression by quantitative real-time RT-PCR analysis for multiple melanoma markers

21 January 2018

1 reference

Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma

21 January 2018

1 reference

Decline in angiogenic factors, such as interleukin-8, indicates response to chemotherapy of metastatic melanoma

21 January 2018

1 reference

Mast cells and cutaneous malignancies

21 January 2018

1 reference

Mast cells: the Jekyll and Hyde of tumor growth

21 January 2018

1 reference

Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression

21 January 2018

1 reference

Improving melanoma classification by integrating genetic and morphologic features

21 January 2018

1 reference

Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma

21 January 2018

1 reference

Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.

21 January 2018

1 reference

Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates

21 January 2018

1 reference

Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy

21 January 2018

1 reference

Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes

21 January 2018

1 reference

Signatures of microRNAs and selected microRNA target genes in human melanoma.

21 January 2018

1 reference

Melanoma MicroRNA signature predicts post-recurrence survival

21 January 2018

1 reference

Identifying and overcoming immune resistance mechanisms in the melanoma tumor microenvironment

21 January 2018

1 reference

The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation

21 January 2018

1 reference

Update on anti-CTLA-4 antibodies in clinical trials

21 January 2018

1 reference

Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade

21 January 2018

1 reference

Inhibition of T cell proliferation by macrophage tryptophan catabolism

21 January 2018

1 reference

Next generation of immunotherapy for melanoma

21 January 2018

1 reference

An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanoma

21 January 2018

1 reference

Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment

21 January 2018

1 reference

Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway

21 January 2018

1 reference

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

21 January 2018

1 reference

Dendritic cell vaccination and immune monitoring.

21 January 2018

1 reference

Selective transduction of mature DC in human skin and lymph nodes by CD80/CD86-targeted fiber-modified adenovirus-5/3.

21 January 2018

1 reference

Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells

21 January 2018

1 reference

An update on malignant melanoma vaccine research: insights into mechanisms for improving the design and potency of melanoma therapeutic vaccines.

21 January 2018

1 reference

Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens

21 January 2018

1 reference

Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant.

21 January 2018

1 reference

Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration

21 January 2018

1 reference

Cytokine-based therapy and biochemotherapy for advanced melanoma

21 January 2018

1 reference

Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.

21 January 2018

1 reference

Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.

21 January 2018

1 reference

Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1/Th2 balance in patients with metastatic melanoma

21 January 2018

1 reference

Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha

21 January 2018

1 reference

Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model

21 January 2018

1 reference

Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma.

21 January 2018

1 reference

Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma

21 January 2018

1 reference

IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells

21 January 2018

1 reference

New perspectives for melanoma immunotherapy: role of IL-12.

21 January 2018

1 reference

Assessment of soluble angiogenic markers in pancreatic cancer.

21 January 2018

1 reference

Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer

21 January 2018

1 reference

Current and emerging biomarkers in breast cancer: prognosis and prediction

21 January 2018

1 reference

Predicting outcome in melanoma: where are we now?

21 January 2018

1 reference

Serum cytokines in metastatic melanoma patients treated with an autologous tumor vaccine.

21 January 2018

1 reference

Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients

21 January 2018

1 reference

Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma.

21 January 2018

1 reference

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.

21 January 2018

1 reference

Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial

21 January 2018

1 reference

Chemotherapy and biologic therapies for melanoma: do they work?

21 January 2018

1 reference

21 January 2018

1 reference

Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.10.81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964610%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference